News

Fetal cfDNA testing can determine if a fetus lacks an antigen that could cause HDFN, avoiding further unnecessary tests and anxiety.

A recent study found that phototherapy induces chemical changes to bilirubin that may lead to inaccurate and nonsensical measurements.

A study showed babies who have ABO-mediated HDFN should be checked for signs of jaundice two to three times during the first day after birth.

Despite advances in screening and treatment, HDFN remains a significant cause of perinatal morbidity and mortality worldwide.

Comprehensive Rh blood typing and genetic analysis can help prevent HDFN and reduce transfusion-related complications.

A global non-interventional registry study aims to evaluate the risk of anemia in infants who may be at risk of HDFN.

A non-invasive antenatal test for Rhesus HDFN can allow for better screening of at-risk women.

Better transfusion record sharing through the Alloantibody Exchange can prevent dangerous delays in identifying antibodies that cause HDFN.

A diverse group of experts collaborated on a set of recommendations for HDFN testing, prevention and treatment.

A newly found blood variant common in Indigenous Australians may raise HDFN risk by triggering anti-D antibodies.